A recent analysis of U.S. mortality data has revealed striking geographic variations in deaths attributed to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The findings suggest a potential link between environmental factors and the prevalence of the neurodegenerative disorder, prompting further scientific inquiry.
The analysis, which examined deaths recorded as motor neuron disease between 2018 and 2024, found that states in the Pacific Northwest, Upper Midwest, and New England experienced higher ALS death rates compared to many Southern and Southwestern states. Idaho, Oregon, and Wyoming recorded the highest rates at 2.5 deaths per 100,000 residents, while Nevada and Hawaii had the lowest at 1.5 per 100,000.
ALS is a progressive disease that destroys nerve cells controlling voluntary muscle movement. It can affect individuals in the prime of their lives, gradually robbing them of the ability to walk, talk, swallow, and breathe. While genetic mutations account for about 10% of cases, the cause of the majority remains unknown, leading researchers to increasingly consider environmental influences.
Several theories have been proposed to explain the observed geographic patterns. One hypothesis suggests a link to latitude, positing that lower vitamin D levels in northern states might increase risk. However, experts like Dr. Eva Feldman, director of the ALS Centre of Excellence at the University of Michigan, note that studies have not established a clear association between ALS and vitamin D exposure. Another theory, linking higher rates to older populations, is also questioned by data showing lower ALS death rates in retirement-heavy states like Florida.
Researchers are increasingly focusing on environmental factors, including pollution from industrial or agricultural activity. Dr. Feldman is leading a long-term study in northern Michigan, a state with high ALS death rates, to investigate the role of pollution. Potential environmental contributors being examined include heavy metals and pesticides, linked to the region's automotive industry and farming practices.
Specific localized theories are also under investigation. In the Pacific Northwest, researchers are examining the potential role of the false morel mushroom. Studies have noted clusters of ALS cases in areas where this mushroom, which contains the toxin gyromitrin, is prevalent. However, experts emphasize that there is no conclusive evidence directly linking false morel consumption to ALS development.
Another theory in Vermont, a state with high ALS death rates, suggests a possible link to toxins produced by cyanobacteria in lakes and rivers, though evidence remains limited. Dr. Melissa Schilling of NYU noted that the geographic distribution of ALS shares similarities with multiple sclerosis, another neurological disorder, suggesting potential shared environmental triggers.
Approximately 33,000 people in the U.S. are currently living with ALS, with an estimated rise to 36,000 by 2030. The disease is more common in white adults and men, typically emerging between ages 55 and 75, though it can affect younger individuals. While there is no cure, treatments can slow progression, but most patients survive two to five years post-diagnosis.
The precise causes for individuals like former NFL player Chris Johnson, who recently revealed his ALS diagnosis, remain unknown. Scientists believe ALS arises from a complex interplay between genetic susceptibility and environmental exposures. Factors such as head trauma, pesticides, and heavy metals have been linked to an increased risk, though direct causation is not definitively proven.